A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

NCT01004445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: Amikacin (BAY41-6551)
DRUG: Amikacin (BAY41-6551)
DRUG: Placebo

Sponsor

Bayer

Collaborators

[object Object]